The Pharmacogenomic Digital Twin for Counterfactual Therapy Selection under Genotype, Phenoconversion, Polypharmacy, Disease Evolution, and Changing Treatment Goals
International Journal of Pharmaceutical Research and Allied Sciences · 2026 · 15 (1) · 22-32
DOI: 10.51847/mp4nwbutcp ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmaceutical Research and Allied Sciences, 2026. Verfasst von Elena Fedorova und 3 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben.
Themen: Medikationssicherheit
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Fedorova, E., Volkov, A., Morozova, I., & Kuznetsov, D. (2026). The Pharmacogenomic Digital Twin for Counterfactual Therapy Selection under Genotype, Phenoconversion, Polypharmacy, Disease Evolution, and Changing Treatment Goals. International Journal of Pharmaceutical Research and Allied Sciences, 15(1), 22-32. https://doi.org/10.51847/mp4nwbutcp
Vancouver
Fedorova E, Volkov A, Morozova I, Kuznetsov D. The Pharmacogenomic Digital Twin for Counterfactual Therapy Selection under Genotype, Phenoconversion, Polypharmacy, Disease Evolution, and Changing Treatment Goals. International Journal of Pharmaceutical Research and Allied Sciences. 2026;15(1):22-32. doi:10.51847/mp4nwbutcp
BibTeX
@article{Fedorova2026,
author = {Fedorova, Elena and Volkov, Alexey and Morozova, Irina and Kuznetsov, Dmitry},
title = {The Pharmacogenomic Digital Twin for Counterfactual Therapy Selection under Genotype, Phenoconversion, Polypharmacy, Disease Evolution, and Changing Treatment Goals},
journal = {International Journal of Pharmaceutical Research and Allied Sciences},
year = {2026},
volume = {15},
number = {1},
pages = {22--32},
doi = {10.51847/mp4nwbutcp}
}
EUVIMED